0001465584-14-000001.txt : 20140429 0001465584-14-000001.hdr.sgml : 20140429 20140429140055 ACCESSION NUMBER: 0001465584-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140429 DATE AS OF CHANGE: 20140429 EFFECTIVENESS DATE: 20140429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CytomX Therapeutics Holdings, LLC CENTRAL INDEX KEY: 0001465584 IRS NUMBER: 261870083 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-216462 FILM NUMBER: 14793058 BUSINESS ADDRESS: STREET 1: 1421 STATE ST., STE. B CITY: SANTA BARBARA STATE: CA ZIP: 93101 BUSINESS PHONE: 805-966-2440 MAIL ADDRESS: STREET 1: 1421 STATE ST., STE. B CITY: SANTA BARBARA STATE: CA ZIP: 93101 FORMER COMPANY: FORMER CONFORMED NAME: CytomX Therapeutics, LLC DATE OF NAME CHANGE: 20090604 D 1 primary_doc.xml X0707 D LIVE 0001465584 CytomX Therapeutics Holdings, LLC 1421 STATE ST., STE. B SANTA BARBARA CA CALIFORNIA 93101 805-966-2440 CALIFORNIA CytomX Therapeutics, LLC Limited Liability Company true Gary Wilcox 1421 State St. Ste. B Santa Barbara CA CALIFORNIA 93101 Director Manager Alan Heeger 1421 St ate St. Ste. B Santa Barbara CA CALIFORNIA 9310 1 Director Manager Michael Pfau 1421 State St. Ste. B Santa Barbara CA CALIFORNIA 93101 Executive Officer Secretary Other Not Applicable 06b false 2014-04-24 false true true Series B-1 Preferred Units false 0 2500000 1423488 1076512 Proceeds used to fund the purchase of Series B-1 Preferred Stock in CytomX Therapeutics, Inc. false 25 0 0 0 false CytomX Therapeutics Holdings, LLC /s/ Michael E. Pfau Michael E. Pfau Secretary 2014-04-29